{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:23:51Z","timestamp":1782545031988,"version":"3.54.5"},"reference-count":18,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:p>The use of cannabidiol in some neurological conditions was allowed by Conselho Regional de Medicina de S\u00e3o Paulo and by Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Specialists on behalf of Academia Brasileira de Neurologia prepared a critical statement about use of cannabidiol and other cannabis derivatives in neurological diseases.<\/jats:p>","DOI":"10.1590\/0004-282x20150041","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T16:39:42Z","timestamp":1431103182000},"page":"371-374","source":"Crossref","is-referenced-by-count":16,"title":["Cannabinoids in neurology \u2013 Brazilian Academy of Neurology"],"prefix":"10.1590","volume":"73","author":[{"given":"Sonia M. D.","family":"Brucki","sequence":"first","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto An\u00edsio","family":"Frota","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Schestatsky","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9lia Henriques","family":"Souza","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Nicole","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Giraldes","family":"Manreza","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda","family":"Mendes","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Comini-Frota","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Vasconcelos","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Tumas","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique B.","family":"Ferraz","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egberto","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Eduardo","family":"Jurno","sequence":"additional","affiliation":[{"name":"Academia Brasileira de Neurologia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/WNL.0000000000001013","article-title":"Synaptic effects of cannabinoids: complexity, behavioral effects and potential clinical implications","volume":"83","author":"Bennaroch EE","year":"2014","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"18781","DOI":"10.3390\/molecules191118781","article-title":"Cannabinoids: new promising agents in the treatment of neurological diseases","volume":"19","author":"Giacoppo S","year":"2014","journal-title":"Molecules"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam R","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.euroneuro.2014.06.007","article-title":"Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial","volume":"24","author":"Ahmed AIA","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.arr.2014.01.007","article-title":"Efficacy and safety of medical cannabinoids in older subjects: a systematic review","volume":"14","author":"Elsen GAH","year":"2014","journal-title":"Ageing Res Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1352458511419700","article-title":"A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex (nabiximols)","volume":"18","author":"Notcutt W","year":"2012","journal-title":"Mult Scler"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1503\/cmaj.091414","article-title":"Smoked cannabis for chronic neuropathic pain: a randomized controlled trial","volume":"182","author":"Ware MA","year":"2010","journal-title":"CMAJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.0b013e318212ab0c","article-title":"Effects of cannabis on cognitive function in patients with multiple sclerosis","volume":"769","author":"Honarmand K","year":"2011","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/jnnp-2012-302468","article-title":"Multiple sclerosis and extract of cannabis: results of MUSEC trial","volume":"83","author":"Zajicek JP","year":"2012","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"82","author":"Koppel BS","year":"2014","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson\u2019s disease: an exploratory double-blind trial","volume":"28","author":"Chagas MH","year":"2014","journal-title":"J Psychopharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson\u2019s disease patients: a case series","volume":"39","author":"Chagas MH","year":"2014","journal-title":"J Clin Pharm Therapeutics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/ALN.0000000000000422","article-title":"Cannabinoid receptor type 1 antagonist, AM251, attenuates mechanical allodynia and thermal hyperalgesia after burn injury","volume":"121","author":"Ueda M","year":"2014","journal-title":"Anesthesiology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/npp.2008.120","article-title":"Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial","volume":"34","author":"Ellis RJ","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1590\/0004-282X20140157","article-title":"Promising treatments for neuropathic pain","volume":"72","author":"Schestatsky P","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2014.08.007","article-title":"Neuropathic orofacial pain: cannabinoids as a therapeutic avenue","volume":"55","author":"McDonough P","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/ALN.0000000000000422","article-title":"Cannabinoid receptor type 1 antagonist, AM251, attenuates mechanical allodynia and thermal hyperalgesia after burn injury","volume":"121","author":"Ueda M","year":"2014","journal-title":"Anesthesiology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog DJ","year":"2005","journal-title":"Neurology"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v73n4\/0004-282X-anp-73-4-0371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T22:42:52Z","timestamp":1495492972000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2015000400371&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0004-282X2015000400371"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20150041","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}